Monitoring lung fluid status using the cardiac component of a thoracic impedance-indicating signal

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8070686
SERIAL NO

11772352

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This patent document describes, among other things, systems and methods for monitoring lung fluid status, such as monitoring the presence or absence of pulmonary edema, in a subject using information about the cardiac impedance-indicating component of a measured impedance-indicating signal. In various examples, an amplitude or contribution change over multiple cardiac cycles of the cardiac impedance-indicating component is used to compute and provide a lung status indication. In various examples, a decreasing amplitude or contribution trend of the cardiac impedance-indicating component signifies an increasing amount of fluid in the subject's lungs, as a greater portion of an injected thoracic impedance measurement current formerly traversing the heart is rerouted through the lung due to the less resistance path created by the fluid accumulation therein. In another example, measurements of the impedance-indicating signal, and thus the cardiac impedance-indicating component, are taken at one or a combination of end-inspiration or end-expiration.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CARDIAC PACEMAKERS INC4100 HAMLINE AVENUE NORTH ST PAUL MN 55112-5798

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Belalcazar, Andres St. Paul, US 31 1152
Lewicke, Aaron Forest Lake, US 16 639

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation